Advertisement

Table of Contents

August 28, 2014; 124 (9)

INSIDE BLOOD COMMENTARIES

  • Microbial messaging to the marrow
    Stephanie S. Watowich
  • The clinical path to integrated genomics in ALL
    Jean-Pierre Bourquin
  • ASXL genes and RUNX1: an intimate connection?
    Klaus H. Metzeler
  • Take (STAT)5: jazzing up T-cell leukemia
    Pierluigi Porcu and Jason Dubovsky
  • What is a true ALCL?
    Wolfram Klapper
  • Targeting the JAK2-STAT5 pathway in CML
    Peter Valent
  • Look out heme, Mac is back in town
    Gregory M. Vercellotti
  • Primetime for γ′
    David H. Farrell

BLOOD WORK

PLENARY PAPER

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

IMMUNOBIOLOGY

LYMPHOID NEOPLASIA

  • Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
    Mark J. Kiel, Thirunavukkarasu Velusamy, Delphine Rolland, Anagh A. Sahasrabuddhe, Fuzon Chung, Nathanael G. Bailey, Alexandra Schrader, Bo Li, Jun Z. Li, Ayse B. Ozel, Bryan L. Betz, Roberto N. Miranda, L. Jeffrey Medeiros, Lili Zhao, Marco Herling, Megan S. Lim and Kojo S. J. Elenitoba-Johnson
  • ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
    Edgardo R. Parrilla Castellar, Elaine S. Jaffe, Jonathan W. Said, Steven H. Swerdlow, Rhett P. Ketterling, Ryan A. Knudson, Jagmohan S. Sidhu, Eric D. Hsi, Shridevi Karikehalli, Liuyan Jiang, George Vasmatzis, Sarah E. Gibson, Sarah Ondrejka, Alina Nicolae, Karen L. Grogg, Cristine Allmer, Kay M. Ristow, Wyndham H. Wilson, William R. Macon, Mark E. Law, James R. Cerhan, Thomas M. Habermann, Stephen M. Ansell, Ahmet Dogan, Matthew J. Maurer and Andrew L. Feldman
  • PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL
    Dalia El-Gamal, Katie Williams, Taylor D. LaFollette, Matthew Cannon, James S. Blachly, Yiming Zhong, Jennifer A. Woyach, Erich Williams, Farrukh T. Awan, Jeffrey Jones, Leslie Andritsos, Kami Maddocks, Chia-Hsien Wu, Ching-Shih Chen, Amy Lehman, Xiaoli Zhang, Rosa Lapalombella and John C. Byrd

MYELOID NEOPLASIA

RED CELLS, IRON, AND ERYTHROPOIESIS

THROMBOSIS AND HEMOSTASIS